Chapman Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67K Hold
777
– – 0.04% 170
2026
Q2
$60.8K Hold
777
– – 0.04% 180
2026
Q1
$67.3K Hold
777
– – 0.05% 169
2025
Q4
$74.6K Hold
777
– – 0.05% 163
2025
Q3
$74K Buy
777
+358
+85% +$32.9K 0.05% 168
2025
Q2
$36.5K Buy
+419
New +$35.5K 0.03% 152
2024
Q4
$33.5K Buy
+419
New +$36.3K 0.03% 157

Other funds holding MDT

Chapman Financial Group's MDT Position: Q3 2026 in Review

Chapman Financial Group held its Medtronic (MDT) position steady in Q3 2026 at 777 shares worth $67K. The position accounts for 0.04% of the portfolio, ranked #170.

Chapman Financial Group first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.6K in Q4 2025. 2,171 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Chapman Financial Group held 777 shares of Medtronic worth $67K as of Q3 2026.
  • Chapman Financial Group left its Medtronic share count unchanged in Q3 2026.
  • Medtronic made up 0.04% of Chapman Financial Group's portfolio in Q3 2026, its #170 holding.
  • Chapman Financial Group first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Chapman Financial Group's Medtronic position peaked at $74.6K in Q4 2025.
  • 2,171 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Chapman Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.